From lipodystrophy syndromes to diabetes mellitus

Lancet

Volumn 357, Issue 9266, 2001, Pages 1379-1381

  Joffe, B I ^a   Panz, V R ^a   Raal, F J ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEINASE INHIBITOR; ROSIGLITAZONE; TROGLITAZONE;

ADIPOCYTE; CELL DIFFERENTIATION; CLINICAL FEATURE; DIABETES MELLITUS; DIMERIZATION; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; INSULIN RESISTANCE; KNOCKOUT GENE; LIPODYSTROPHY; LIVER DYSFUNCTION; NONHUMAN; NOTE; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

EID: 0035810593     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04616-X     Document Type: Note

References (20)

1. A Carr K Samaras DJ Chisholm DA Cooper Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance Lancet 351 1998 1881 1883
2. VC Pardini IM Victoria SM Rocha Leptin levels, β-cell function and insulin sensitivity in families with congenital and acquired generalized lipoatrophic diabetes J Clin Endocrinol Metab 83 1998 503 508
3. M-T Van der Merwe VR Panz NJ Crowther Free fatty acid and insulin levels: relationship to leptin levels and body composition in various patient groups from South Africa Int J Obesity 23 1999 909 917
4. H Cao RA Hegele Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy Hum Molec Genet 9 2000 109 112
5. M Seip O Trygstad Generalized lipodystrophy, congenital and acquired (lipoatrophy) Acta Paediatr Scand 413 suppl 1996 2 28
6. C Vigouroux E Khallouf C Bourut Genetic exclusion of 14 candidate genes in lipoatrophic diabetes using linkage analysis in 10 consanguineous families J Clin Endocrinol Metab 82 1997 3438 3444
7. A Garg R Wilson R Barnes A gene for congenital generalized lipodystrophy maps to human chromosome 1934 J Clin Endocrinol Metab 84 1999 3390 3394
8. J Magré C Reynet J Capeau M-J Blivet J Picard In vitro studies of insulin resistance in patients with lipoatrophic diabetes: evidence of heterogeneous postbinding defects Diabetes 37 1988 421 428
9. VR Panz BI Joffe FJ Raal JR Wing M-A Kedda HC Seftel The insulin receptor in South African families with lipo-atrophic diabetes mellitus S Afr Med J 87 1997 1277 1283
10. J Auwerx PPARγ, the ultimate thrifty gene Diabetologia 42 1999 1033 1049
11. GR Collier JS McMillan Windmill Becaon: a novel gene involved in the regulation of energy balance Diabetes 49 2000 1766 1771
12. K Reue M Péterfy Mouse models of lipodystrophy Curr Atheroscl Rep 2 2000 390 396
13. VR Panz JR Wing FJ Raal M-A Kedda BI Joffe Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis Clin Endocrinol 46 1997 365 368
14. E Arioglu J Duncan-Morin N Sebring Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes Ann Intern Med 133 2000 263 274
15. K Schoonjans B Staels J Auwerx Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression J Lipid Res 37 1996 907 925
16. K Schoonjans J Auwerx Thiazolidinediones: an update Lancet 355 2000 1008 1010
17. PJ Randle CN Hales PB Garland EA Newsholm The glucose fatty-acid cycle: its roles in insulin sensitivity and the metabolic disturbances of diabetes mellitus Lancet 1 1963 785 789
18. CR Kahn L Chen SE Cohen Unraveling the mechanism of action of thiazolinediones J Clin Invest 106 2000 1305 1307
19. L Chao B Marcus-Samuels MM Mason Adipose tissue is required for the antidiabetic, but not for the hypolipidemic effect of thiazolidinediones J Clin Invest 106 2000 1221 1228
20. B Joffe P Zimmet The thrifty genotype in type 2 diabetes Endocrine 9 1998 139 141